4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001209191-21-009112
President and CEO sold 778 shares at $7.66 ($5,959)
- President and CEO acquired 1,785 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shukla Sanjay President and CEO | 2021-02-06 | Option exercise | +1,785 | 9,076 | D | ||
| Shukla Sanjay President and CEO | 2021-02-09 | Sale | −778 | $7.66 | $5,959 | 8,298 | D |
| Derivatives | |||||||
| Shukla Sanjay President and CEO | 2021-02-06 | Option exercise · Restricted Stock Unit | −1,785 | 0 | D | ||
| Open-market sales · 778 sh · avg $7.66 · $5,959 | |||||||
Loading xslF345X03/doc4.xml…